The emerging role of immunotherapy in advanced urothelial cancers. – UroToday
|
The emerging role of immunotherapy in advanced urothelial cancers.
UroToday Recent Food and Drug Administration (FDA) approval of five new immune checkpoint inhibitors for the treatment of metastatic urothelial cancer represents the first major treatment breakthrough for this disease since the introduction of combination … |
